Home › Liver Cancer (Hepatocellular Carcinoma) › New York › The Bronx
Liver Cancer (Hepatocellular Carcinoma) clinical trials in The Bronx, NY
6 studies for Liver Cancer (Hepatocellular Carcinoma) are looking for participants at sites in and around The Bronx (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
RecruitingPhase 1/2
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
RecruitingPhase 3
- Montefiore Medical Center-Einstein Campus, The Bronx
- Montefiore Medical Center - Moses Campus, The Bronx
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
Recruiting
- Montefiore Medical Center, The Bronx
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Recruiting
- James J. Peters VA Medical Center, Bronx, NY, The Bronx
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
RecruitingPhase 2
- Montefiore Medical CenterMontefiore Medical Park, The Bronx
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
RecruitingPhase 2
- Montefiore Medical Center, The Bronx
Liver Cancer (Hepatocellular Carcinoma) trials in other cities
- Houston, TX31 studies
- New York City, NY24 studies
- Dallas, TX19 studies
- Los Angeles, CA19 studies
- Boston, MA18 studies
- Cleveland, OH18 studies
- Chicago, IL16 studies
- Philadelphia, PA16 studies
- Pittsburgh, PA15 studies
- San Francisco, CA14 studies
- Orange, CA14 studies
- Jacksonville, FL14 studies
Other studies in The Bronx
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer17 studies
- Acute Myeloid Leukemia15 studies
- Lung Cancer13 studies
- Cancer (all types)12 studies
- Cardiovascular Disease12 studies
- Heart Failure11 studies
- Prostate Cancer11 studies
- Metastatic Cancer9 studies
- Colorectal Cancer9 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Myelodysplastic Syndromes9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.